Specific CT 3D rendering of the treatment zone after Irreversible Electroporation (IRE) in a pig liver model: the "Chebyshev Center Concept" to define the maximum treatable tumor size.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3926307)

Published in BMC Med Imaging on January 10, 2014

Authors

Dominik Vollherbst, Stefan Fritz, Sascha Zelzer, Miguel F Wachter, Maya B Wolf, Ulrike Stampfl, Daniel Gnutzmann, Nadine Bellemann, Anne Schmitz, Jürgen Knapp, Philippe L Pereira, Hans U Kauczor, Jens Werner, Boris A Radeleff, Christof M Sommer1

Author Affiliations

1: Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany. christof.sommer@med.uni-heidelberg.de.

Articles cited by this

Tissue ablation with irreversible electroporation. Ann Biomed Eng (2005) 4.64

Irreversible electroporation: a new ablation modality--clinical implications. Technol Cancer Res Treat (2007) 3.37

Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol (2011) 2.55

In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng (2006) 2.34

Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29

Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol (2009) 2.12

Irreversible electroporation in medicine. Technol Cancer Res Treat (2007) 2.11

Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat (2007) 1.94

Irreversible electroporation for the ablation of liver tumors: are we there yet? Arch Surg (2012) 1.74

Irreversible electroporation in porcine liver: acute computed tomography appearance of ablation zone with histopathologic correlation. J Comput Assist Tomogr (2013) 1.32

Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol (2012) 1.29

Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology (2004) 1.24

Irreversible electroporation in porcine liver: short- and long-term effect on the hepatic veins and adjacent tissue by CT with pathological correlation. Invest Radiol (2012) 1.17

Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol (2009) 1.04

Experimental and clinical radiofrequency ablation: proposal for standardized description of coagulation size and geometry. Ann Surg Oncol (2007) 0.98

Multimodality non-rigid image registration for planning, targeting and monitoring during CT-guided percutaneous liver tumor cryoablation. Acad Radiol (2010) 0.95

Size determination and response assessment of liver metastases with computed tomography--comparison of RECIST and volumetric algorithms. Eur J Radiol (2012) 0.92

The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma. Radiol Oncol (2012) 0.89

Radiofrequency ablation of liver tumors: quantitative assessment of tumor coverage through CT image processing. BMC Med Imaging (2013) 0.84

Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma. PLoS One (2013) 0.84

Angiography in the isolated perfused kidney: radiological evaluation of vascular protection in tissue ablation by nonthermal irreversible electroporation. Cardiovasc Intervent Radiol (2011) 0.81

Optimisation of the coagulation zone for thermal ablation procedures: a theoretical approach with considerations for practical use. Int J Hyperthermia (2013) 0.79

Evaluation of hepatocellular carcinoma size using two-dimensional and volumetric analysis: effect on liver transplantation eligibility. Acad Radiol (2011) 0.78

Renal artery embolization combined with radiofrequency ablation in a porcine kidney model: effect of small and narrowly calibrated microparticles as embolization material on coagulation diameter, volume, and shape. Cardiovasc Intervent Radiol (2010) 0.77

Articles by these authors

Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg (2012) 7.26

IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology (2002) 3.48

Genetic basis of mitochondrial function and morphology in Saccharomyces cerevisiae. Mol Biol Cell (2002) 3.27

Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med (2008) 2.18

Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14

Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg (2011) 2.02

Comparison of two intraosseous infusion systems for adult emergency medical use. Resuscitation (2008) 1.97

Chronic pancreatitis--definition, etiology, investigation and treatment. Dtsch Arztebl Int (2013) 1.82

Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78

Insertion of totally implantable venous access devices: an expertise-based, randomized, controlled trial (NCT00600444). Ann Surg (2011) 1.77

CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol (2012) 1.76

European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis (2013) 1.75

Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy, and necrosis in pancreatitis. Gastroenterology (2009) 1.72

Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas (2011) 1.64

Improvement of surgical results for pancreatic cancer. Lancet Oncol (2013) 1.60

More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol (2011) 1.56

Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg (2009) 1.54

Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas (2012) 1.53

Anaplastic pancreatic cancer: Presentation, surgical management, and outcome. Surgery (2010) 1.49

Immunohistochemical characterization of specific inflammatory tissue reactions following embolization with four different spherical agents in the minipig kidney model. J Vasc Interv Radiol (2009) 1.43

MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol (2012) 1.43

Feasibility and effectiveness of a new algorithm in preventing hepatic artery thrombosis after liver transplantation. J Gastrointest Surg (2008) 1.41

Stimulation of Central α2 Receptors Attenuates Experimental Necrotizing Pancreatitis. Pancreas (2016) 1.38

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36

Subcapsular liver hematoma in HELLP syndrome: Evaluation of diagnostic and therapeutic options--a unicenter study. Am J Obstet Gynecol (2004) 1.33

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol (2012) 1.28

Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One (2012) 1.25

The inner membrane protein Mdm33 controls mitochondrial morphology in yeast. J Cell Biol (2003) 1.22

Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol (2012) 1.21

Giant mullerian duct cyst with malignant transformation in 15-year-old boy. Urology (2006) 1.20

Postoperative pancreatic fistula. Surgeon (2010) 1.17

Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Int J Cancer (2013) 1.15

4D-MRI analysis of lung tumor motion in patients with hemidiaphragmatic paralysis. Radiother Oncol (2009) 1.13

Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol (2005) 1.13

MR imaging for diagnosing cysto-biliary fistulas in cystic echinococcosis. Eur J Radiol (2007) 1.11

Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging (2008) 1.11

Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg (2010) 1.08

Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment. J Pathol (2012) 1.08

Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg (2011) 1.08

The Medical Imaging Interaction Toolkit: challenges and advances : 10 years of open-source development. Int J Comput Assist Radiol Surg (2013) 1.07

Surgical management of severe pancreatitis including sterile necrosis. J Hepatobiliary Pancreat Surg (2002) 1.06

Management of infection in acute pancreatitis. J Hepatobiliary Pancreat Surg (2002) 1.05

Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol (2005) 1.03

Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. AJR Am J Roentgenol (2005) 1.03

Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection. Radiat Oncol (2013) 1.03

Interventional oncologic approaches to liver metastases. Radiology (2013) 1.03

Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg (2015) 1.02

A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas (2014) 1.01

Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Int J Cancer (2014) 1.01

Reactive oxygen species in the immune system. Int Rev Immunol (2013) 1.01

Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas. J Comput Assist Tomogr (2009) 1.00

Performing MR-guided biopsies in clinical routine: factors that influence accuracy and procedure time. Eur Radiol (2011) 0.99

Decrease in clinically relevant pancreatic fistula by coverage of the pancreatic remnant after distal pancreatectomy. Surgery (2012) 0.99

Reduction of radiation exposure and improvement of image quality with BMI-adapted prospective cardiac computed tomography and iterative reconstruction. Eur J Radiol (2011) 0.99

Radiologic versus endoscopic evaluation of the conduit after esophageal resection: a prospective, blinded, intraindividually controlled diagnostic study. Surg Endosc (2014) 0.99

Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Abdom Imaging (2008) 0.98

Pancreatic cancer susceptibility loci and their role in survival. PLoS One (2011) 0.98

Multipolar radiofrequency ablation with internally cooled electrodes: experimental study in ex vivo bovine liver with mathematic modeling. Radiology (2006) 0.97

Successful arterial embolization of a giant pseudoaneurysm of the gastroduodenal artery secondary to chronic pancreatitis with literature review. J Radiol Case Rep (2012) 0.97

Resection of the intrapancreatic bile duct preserving the pancreas. J Hepatobiliary Pancreat Surg (2008) 0.97

Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Oncotarget (2014) 0.96

Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer. Surgery (2012) 0.96

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95

Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer. Int J Oncol (2011) 0.95

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. J Virol (2014) 0.95

Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? Am J Surg (2011) 0.95

Experimental liver embolization with four different spherical embolic materials: impact on inflammatory tissue and foreign body reaction. Cardiovasc Intervent Radiol (2009) 0.94

Diagnostic and interventional MRI of the sacroiliac joints using a 1.5-T open-bore magnet: a one-stop-shopping approach. AJR Am J Roentgenol (2008) 0.93

Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis. BMC Cancer (2012) 0.93

Scars and perforator-based flaps in the abdominal region: a contraindication? Can J Surg (2010) 0.93

Pylorus resection in partial pancreaticoduodenectomy: impact on delayed gastric emptying. Am J Surg (2013) 0.92

Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: initial results. World J Gastroenterol (2009) 0.92

Single coronary artery with anomalous rising of the right coronary artery: a rare coronary anomaly diagnosed by 256-multidetector computed tomography. Case Rep Med (2011) 0.92

Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg (2015) 0.92

Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy. Cancer Immunol Immunother (2013) 0.92

Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell Metab (2011) 0.92

Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer (2008) 0.91

Survival data justifies resection for pancreatic metastases. Ann Surg Oncol (2009) 0.91

Ischemic acute pancreatitis: clinical features of 11 patients and review of the literature. Am J Surg (2008) 0.91

Uncinate process first--a novel approach for pancreatic head resection. Langenbecks Arch Surg (2010) 0.91

Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg (2014) 0.91

Surgical therapy of chronic pancreatitis: indications, techniques and results. Int J Surg (2009) 0.90

In vivo efficiency of four commercial monopolar radiofrequency ablation systems: a comparative experimental study in pig liver. Invest Radiol (2003) 0.90

Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis. Crit Care (2008) 0.90

Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery (2012) 0.90

Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol (2006) 0.90

Midterm results of uterine artery embolization using narrow-size calibrated embozene microspheres. Cardiovasc Intervent Radiol (2010) 0.89

Follow-up investigation of open trigger digit release. Arch Orthop Trauma Surg (2011) 0.89

Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease. Nat Rev Gastroenterol Hepatol (2012) 0.89

Normative data on wrist function. J Hand Surg Am (2012) 0.89

R0 in pancreatic cancer surgery: surgery, pathology, biology, or definition matters? Ann Surg (2010) 0.89